Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 587-594

  Li, Ellen ^a   Ji, Ping ^a   Ouyang, Nengtai ^a   Zhang, Yuanhao ^b   Wang, Xin Yu ^a   Rubin, Deborah C ^d   Davidson, Nicholas O ^d   Bergamaschi, Roberto ^a   Shroyer, Kenneth R ^a   Burke, Stephanie ^a   Zhu, Wei ^b   Williams, Jennie L ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Caucasian American; Colon cancer; MicroRNA; Quantitative reverse transcriptase polymerase chain reaction; Racial health disparity; Repeated measures analysis of variance

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 1; MICRORNA 128; MICRORNA 133A; MICRORNA 135B; MICRORNA 152; MICRORNA 17; MICRORNA 182; MICRORNA 183; MICRORNA 18A; MICRORNA 18B; MICRORNA 200A; MICRORNA 202; MICRORNA 203; MICRORNA 204; MICRORNA 21; MICRORNA 210; MICRORNA 222; MICRORNA 224; MICRORNA 31; MICRORNA 424; MICRORNA 503; MICRORNA 552; MICRORNA 7; MICRORNA 96; MICRORNA H1; PARAFFIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; MIRN182 MICRORNA, HUMAN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; FROZEN SECTION; GENE EXPRESSION; GENETIC ASSOCIATION; HEALTH DISPARITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RACE DIFFERENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEX DIFFERENCE; UPREGULATION; CAUCASIAN; COLON TUMOR; DNA MICROARRAY; ETHNOLOGY; GENETICS; MORTALITY; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AFRICAN AMERICANS; AGED; COLONIC NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84902577343     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2469     Document Type: Article

References (43)

1. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D and Morris CD: Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 300: 1417-1422, 2008.
2. Alexander D, Jhala N, Chatla C, et al: High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103: 2163-2170, 2005. (Pubitemid 40605125)
3. Chien C, Morimoto LM, Tom J and Li CI: Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer 104: 629-639, 2005. (Pubitemid 41022822)
4. Clegg LX, Li FP, Hankey BF, Chu K and Edwards BK: Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 162: 1985-1993, 2002.
5. Cooper GS, Yuan Z and Rimm AA: Racial disparity in the incidence and case-fatality of colorectal cancer: analysis of 329 United States counties. Cancer Epidemiol Biomarkers Prev 6: 283-285, 1997. (Pubitemid 27172893)
6. Hodgson DC, Fuchs CS and Ayanian JZ: Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93: 501-515, 2001. (Pubitemid 32318429)
7. Hodgson DC, Zhang W, Zaslavsky AM, Fuchs CS, Wright WE and Ayanian JZ: Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst 95: 708-716, 2003. (Pubitemid 36665498)
8. Mayberry RM, Coates RJ, Hill HA, et al: Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 87: 1686-1693, 1995.
9. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A and Edwards BK (eds): SEER Cancer Statistics Review, 1973-1994. National Cancer Institute, Bethesda, MD, 1997.
10. Weber TK, Chin HM, Rodriguez-Bigas M, et al: Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA 281: 2316-2320, 1999. (Pubitemid 29289824)
11. Carethers JM: Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys 10: 59-67, 1999.
12. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ and Kerin MJ: MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009: 950201, 2009.
13. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
14. Yang L, Belaguli N and Berger DH: MicroRNA and colorectal cancer. World J Surg 33: 638-646, 2009.
15. Cummins JM, He Y, Leary RJ, et al: The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687-3692, 2006. (Pubitemid 43376616)
16. Callari M, Dugo M, Musella V, et al: Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 7: e45105, 2012.
17. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
18. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
19. Sarver AL, French AJ, Borralho PM, et al: Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 9: 401, 2009.
20. Xi Y, Shalgi R, Fodstad O, Pilpel Y and Ju J: Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12: 2014-2024, 2006.
21. Fu J, Tang W, Du P, et al: Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol 6: 68, 2012.
22. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
23. Voorhoeve PM, le Sage C, Schrier M, et al: A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181, 2006.
24. Shell S, Park SM, Radjabi AR, et al: Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400-11405, 2007. (Pubitemid 47175152)
25. Huang Q, Gumireddy K, Schrier M, et al: The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210, 2008. (Pubitemid 351194050)
26. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
27. Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008. (Pubitemid 351574906)
28. Zhou BY and Wong WH: A bootstrap-based non-parametric ANOVA method with applications to factorial microarray data. Statistica Sinica 21: 495-514, 2011.
29. Xu XM, Qian JC, Deng ZL, et al: Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett 4: 339-345, 2012.
30. Meiri E, Levy A, Benjamin H, et al: Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res 38: 6234-6246, 2010.
31. Reid JF, Sokolova V, Zoni E, et al: miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 10: 504-515, 2012.
32. Hamfjord J, Stangeland AM, Hughes T, et al: Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 7: e34150, 2012.
33. Piepoli A, Tavano F, Copetti M, et al: MiRNA expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One 7: e33663, 2012.
34. Liu H, Du L, Wen Z, et al: Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value. Int J Colorectal Dis 28: 697-703, 2013.
35. Myatt SS and Lam EW: The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847-859, 2007. (Pubitemid 350006253)
36. Paik JH, Kollipara R, Chu G, et al: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323, 2007. (Pubitemid 46123514)
37. CGA N: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337, 2012.
38. Bovell LC, Shanmugam C, Putcha BD, et al: The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res 19: 3955-3965, 2013.
39. He LY, Wei X, Du L, et al: Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis. J Huazhong Univ Sci Technolog Med Sci 33: 205-211, 2013.
40. Huynh C, Segura MF, Gaziel-Sovran A, et al: Efficient in vivo microRNA targeting of liver metastasis. Oncogene 30: 1481-1488, 2011.
41. Kauh J, Brawley OW and Berger M: Racial disparities in colorectal cancer. Curr Probl Cancer 31: 123-133, 2007. (Pubitemid 46818419)
42. Carethers JM, Chauhan DP, Fink D, et al: Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 117: 123-131, 1999. (Pubitemid 29297628)
43. Liu S, Howell PM and Riker AI: Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. Ann Surg Oncol 20: 1745-1752, 2013.